Cart
sales@molnova.com
Pomalidomide-C4-COOH
CAS No. 2225940-48-5
Pomalidomide-C4-COOH ( —— )
Catalog No. M28258 CAS No. 2225940-48-5
Pomalidomide-C4-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | Get Quote |
|
| 5MG | 88 | Get Quote |
|
| 10MG | 128 | Get Quote |
|
| 25MG | 230 | Get Quote |
|
| 50MG | 347 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePomalidomide-C4-COOH
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-C4-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
DescriptionPomalidomide-C4-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-HT1D;5-HT1B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225940-48-5
-
Formula Weight373.4
-
Molecular FormulaC18H19N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCCCNc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Da Silva RA, et al. Feeding behavior after metergoline or GR-46611 injections into the paraventricular nucleus of the hypothalamus in the pigeon. Behav Brain Res. 2007 May 16;179(2):248-57.
molnova catalog
related products
-
NXY-059
NXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo.
-
Substance P (1-7)(TF...
Substance P (1-7)(TFA) is a fragment of the neuropeptide, substance P (SP).
-
Quinolinic acid
Quinolinic acid is an endogenous N-methyl-D-aspartate (NMDA) receptor agonist synthesized from L-tryptophan via the kynurenine pathway.
